1. Home
  2. BRX vs RGEN Comparison

BRX vs RGEN Comparison

Compare BRX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brixmor Property Group Inc.

BRX

Brixmor Property Group Inc.

HOLD

Current Price

$25.82

Market Cap

8.1B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.92

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRX
RGEN
Founded
2011
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BRX
RGEN
Price
$25.82
$162.92
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$29.82
$174.90
AVG Volume (30 Days)
3.2M
701.7K
Earning Date
02-09-2026
10-28-2025
Dividend Yield
4.77%
N/A
EPS Growth
N/A
N/A
EPS
1.08
0.03
Revenue
$1,346,289,000.00
$707,890,000.00
Revenue This Year
$7.62
$17.84
Revenue Next Year
$4.41
$12.57
P/E Ratio
$23.86
$6,381.36
Revenue Growth
5.75
11.74
52 Week Low
$22.29
$102.97
52 Week High
$28.61
$182.52

Technical Indicators

Market Signals
Indicator
BRX
RGEN
Relative Strength Index (RSI) 48.23 55.66
Support Level $25.49 $156.01
Resistance Level $26.08 $165.02
Average True Range (ATR) 0.40 4.42
MACD 0.09 -0.73
Stochastic Oscillator 74.92 51.63

Price Performance

Historical Comparison
BRX
RGEN

About BRX Brixmor Property Group Inc.

Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: